Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,020,018
  • Shares Outstanding, K 350,001
  • Annual Sales, $ 3,765 M
  • Annual Income, $ 182,000 K
  • 60-Month Beta N/A
  • Price/Sales 1.60
  • Price/Cash Flow N/A
  • Price/Book 0.88
Trade BLCO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.84
  • Most Recent Earnings 0.31 on 11/02/22
  • Next Earnings Date 02/22/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-3851 Ophthalmic Goods

    Medical Services

Options Overview Details

View History
  • Implied Volatility 46.83% ( +1.34%)
  • Historical Volatility 23.77%
  • IV Percentile 17%
  • IV Rank 59.86%
  • IV High 75.67% on 05/26/22
  • IV Low 3.81% on 12/08/22
  • Put/Call Vol Ratio 13.00
  • Today's Volume 98
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 1,034
  • Open Int (30-Day) 971

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.22
  • Number of Estimates 6
  • High Estimate 0.24
  • Low Estimate 0.21
  • Prior Year N/A
  • Growth Rate Est. (year over year) -99.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.51 +10.32%
on 01/03/23
17.44 -1.89%
on 01/20/23
+1.60 (+10.32%)
since 12/30/22
3-Month
12.79 +33.78%
on 11/03/22
17.44 -1.89%
on 01/20/23
+2.57 (+17.68%)
since 10/28/22

Most Recent Stories

More News
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year...

BLCO : 17.11 (-0.52%)
BLCO.TO : 22.94 (+0.13%)
Bausch + Lomb Acquires AcuFocus, Inc.

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc. (“AcuFocus”), a privately...

BLCO : 17.11 (-0.52%)
BLCO.TO : 22.94 (+0.13%)
Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision...

BLCO : 17.11 (-0.52%)
BLCO.TO : 22.94 (+0.13%)
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, has published a company...

BLCO : 17.11 (-0.52%)
BLCO.TO : 22.94 (+0.13%)
Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief...

BLCO : 17.11 (-0.52%)
BLCO.TO : 22.94 (+0.13%)
Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Novaliq GmbH, a biopharmaceutical company...

BLCO : 17.11 (-0.52%)
BLCO.TO : 22.94 (+0.13%)
Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national...

BLCO : 17.11 (-0.52%)
BLCO.TO : 22.94 (+0.13%)
Implied Volatility Surging for Bausch + Lomb (BLCO) Stock Options

Investors need to pay close attention to Bausch + Lomb (BLCO) stock based on the movements in the options market lately.

BLCO : 17.11 (-0.52%)
Why Bausch Health Stock Is Jumping Today

The company's exchange offer for existing senior notes appears to be going well.

BHC : 7.82 (-6.68%)
BLCO : 17.11 (-0.52%)
BLCO vs. DOCS: Which Stock Should Value Investors Buy Now?

BLCO vs. DOCS: Which Stock Is the Better Value Option?

BLCO : 17.11 (-0.52%)
DOCS : 34.22 (-2.09%)

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 17.48
2nd Resistance Point 17.38
1st Resistance Point 17.24
Last Price 17.11
1st Support Level 17.00
2nd Support Level 16.90
3rd Support Level 16.76

See More

52-Week High 20.20
Fibonacci 61.8% 17.14
Last Price 17.11
Fibonacci 50% 16.20
Fibonacci 38.2% 15.26
52-Week Low 12.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar